Omalizumab With Oral Food Immunotherapy With Food Allergies Open Label Safety Study in a Single Center

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01510626
Recruitment Status : Completed
First Posted : January 16, 2012
Last Update Posted : December 10, 2015
Information provided by (Responsible Party):
Kari Christine Nadeau, Stanford University

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2014
  Study Completion Date : December 2015